Delivery Order SPE2DB25D9312-SPE2DB25FWUWS
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,353.77 to DMS Pharmaceutical Group Inc. for the supply of Lenvima 8 mg daily dose tablets (60-count) with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under the company's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lenvima 8 mg daily dose tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025. The contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,353.77 by the Defense Logistics Agency on August 22, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count). This firm fixed-price delivery order is scheduled for completion by September 15, 2025, with performance taking place at the vendor's Park Ridge location. The award was made without a set-aside designation, reflecting...
- The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $22,707.56 to DMS Pharmaceutical Group Inc. for the supply of LENVIMA 10 mg daily dose (30-count) medication. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without set-aside designation. The delivery order is scheduled for completion by September 22, 2025, and represents a discrete fulfillment under the company's broader...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency (DLA) on September 16, 2025. The contract calls for the delivery of Lenvima 20 mg daily dose tablets in quantities of 60 units, with an ultimate completion date of October 7, 2025. This delivery order was issued without a set-aside designation, leveraging the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,353.77 by the Defense Logistics Agency on September 9, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count packaging). The contract carries an ultimate completion date of September 30, 2025, and includes no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $124,891.53 for LENVIMA 20 mg daily dose medication (60-unit supply) by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. This delivery order, which carries no set-aside designation, is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for LENVIMA 8 mg daily dose medication (60-count supply). The contract is valued at $29,624.58 and operates under a firm fixed-price delivery order structure with an ultimate completion date of October 8, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency for the supply of Lenvima 14 mg daily dose medication in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, is scheduled for completion by October 1, 2025, with no set-aside designation applied. The award represents a continuation of DMS Pharmaceutical Group's...
- SPE2DB25D9312Indefinite Delivery Contract
- SPE2DB25D9312-SPE2DB25FWUWSDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $34,061.31 to DMS Pharmaceutical Group Inc. for the supply of Lenvima 8 mg daily dose tablets (60-count). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location with an ultimate completion date of October 6, 2025. This award was made without a set-aside designation, and the contract was executed on September 15, 2025. The delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. Lenvima is an oncology medication used in the treatment of various cancers, and this delivery order represents a routine pharmaceutical supply replenishment to support military medical operations. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently winning delivery orders under its DLA indefinite delivery contract for branded and generic prescription drugs, biologics, and specialized medical products. The company's portfolio of federal awards demonstrates its capability to efficiently distribute medications and medical supplies to DoD healthcare sites across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.1k | 9/15/25 |